Cutler Group’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-115
Closed -$17.7K 3610
2023
Q3
$17K Buy
115
+100
+667% +$16K ﹤0.01% 2131
2023
Q2
$2K Sell
15
-350
-96% -$55.9K ﹤0.01% 2960
2023
Q1
$59K Buy
365
+364
+36,400% +$58.9K 0.01% 1239
2022
Q4
$0 Sell
1
-99
-99% -$15.7K ﹤0.01% 4380
2022
Q3
$14K Sell
100
-400
-80% -$60.5K ﹤0.01% 2856
2022
Q2
$72K Buy
500
+400
+400% +$59.6K 0.01% 1665
2022
Q1
$16K Sell
100
-100
-50% -$16.2K ﹤0.01% 3227
2021
Q4
$37K Hold
200
﹤0.01% 2624
2021
Q3
$40K Buy
+200
New +$42K ﹤0.01% 2690
2020
Q3
Sell
-1,400
Closed -$228K 4658
2020
Q2
$228K Buy
+1,400
New +$213K 0.02% 809
2020
Q1
Sell
-1,531
Closed -$206K 4006
2019
Q4
$213K Buy
1,531
+900
+143% +$118K 0.01% 795
2019
Q3
$74K Sell
631
-40
-6% -$4.97K 0.01% 1256
2019
Q2
$86K Buy
+671
New +$82.7K 0.01% 1179
2018
Q4
Sell
-1,071
Closed -$145K 3919
2018
Q3
$145K Buy
+1,071
New +$139K 0.01% 1001
2018
Q2
Sell
-671
Closed -$79.1K 4184
2018
Q1
$80K Buy
+671
New +$84.2K 0.01% 1346
2017
Q4
Sell
-200
Closed -$25.5K 4890
2017
Q3
$26K Buy
+200
New +$26K ﹤0.01% 2863
2017
Q1
Sell
-226
Closed -$26.4K 6355
2016
Q4
$24K Sell
226
-3,025
-93% -$329K ﹤0.01% 3259
2016
Q3
$374K Sell
3,251
-1,500
-32% -$171K 0.02% 765
2016
Q2
$486K Buy
4,751
+4,159
+703% +$444K 0.02% 605
2016
Q1
$61K Buy
+592
New +$61.7K ﹤0.01% 2110

Other funds holding BBH

Cutler Group's BBH Position: Q4 2023 in Review

Cutler Group sold out of VanEck Biotech ETF (BBH) in Q4 2023, closing a stake of 115 shares — an estimated $17.7K sold.

Cutler Group first reported a position in BBH in Q1 2016 and held it in 20 quarters. The position peaked at $486K in Q2 2016. 116 funds tracked by Wall St. Rank hold BBH as of Q4 2023.

  • Cutler Group reported no remaining VanEck Biotech ETF position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 115 VanEck Biotech ETF shares in Q4 2023, an estimated $17.7K.
  • Cutler Group first reported a position in VanEck Biotech ETF in Q1 2016 and held it in 20 quarters.
  • Cutler Group's VanEck Biotech ETF position peaked at $486K in Q2 2016.
  • 116 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.